Douglass Hanly Moir Pathology

What Douglass Hanly Moir Pathology does

Douglass Hanly Moir Pathology (DHM) is a privately held diagnostic pathology practice headquartered in Macquarie Park, New South Wales, and operating as a wholly owned subsidiary of the publicly listed Sonic Healthcare group (ASX: SHL). Founded in 1996, the company employs 501–1,000 staff and serves patients and referring clinicians across New South Wales and north-west Victoria through a network of more than 500 collection centres, three metropolitan laboratories, regional laboratories, and a central laboratory operating 24 hours per day, 365 days per year. Its clinical workforce comprises more than 95 pathologists covering all major pathology subdisciplines, with specialty practices branded GynaePath (gynaecological), Sonic Skin Dx (dermatopathology), Sonic Uro Dx (urological), Sonic Genetics (genetic and reproductive carrier screening), and DNALabs (parentage/relationship DNA). Patient-facing differentiation includes the Smileyscope virtual-reality headset partnership for anxiety reduction during blood draws and online appointment booking.

The company's core technology stack is NATA-accredited laboratory testing infrastructure spanning routine clinical chemistry, haematology, microbiology, immunology, anatomical pathology, and advanced molecular diagnostics including MetaPanel clinical metagenomics, non-invasive prenatal testing (NIPT), fetal Rhesus screening, pharmacogenomics (PGx), and reproductive carrier screening. Digital platforms include Sonic Dx for electronic clinician result delivery, eSupplies for pathology consumables ordering, Sonic Edu for clinician continuing-professional-development content, and integration with Australia's My Health Record system for patient access. Cardiac services (ECG, Holter monitoring, ambulatory blood pressure monitoring) are delivered through an in-house cardiologist, a less common capability within Australian pathology providers. Certifications include NATA accreditation, RCPA-guideline compliance, Medicare Benefits Schedule participating-provider status, and Australian Privacy Act compliance.

DHM's revenue model combines three streams: bulk-billed Medicare-rebatable pathology tests subject to a maximum A$210/day out-of-pocket cap for eligible outpatients; privately billed fees for non-Medicare specialist tests (e.g., Active B12 confirmatory, drug and alcohol chain-of-custody); and direct billing arrangements with four major OSHC/OSV insurers (AHM, Allianz, Bupa, Medibank Private) for international students and visitors. Commercial-pathology lines (Drug & Alcohol, Occupational Exposure, Health & Wellness, Workplace Testing) and corporate immunity screening (Measles, Mumps, Rubella, Varicella, Hepatitis B, TB at A$25–$75 per test) provide non-Medicare revenue. Customer segments fall into two primary channels — referring clinicians (GPs, specialists, private hospitals, nursing homes, community health services) routed through Sonic Dx, and patients accessing collection centres directly — with overseas students/visitors and healthcare-worker/student immunity candidates as secondary segments.

Name

Douglass Hanly Moir Pathology

Legal name

Douglass Hanly Moir Pathology

Website

https://dhm.com.au

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Douglass Hanly Moir Pathology is a Sonic Healthcare-owned diagnostic pathology practice operating 500+ collection centres and NATA-accredited laboratories across New South Wales and north-west Victoria, serving patients, GPs, specialists, private hospitals, and nursing homes with routine and specialty pathology testing.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

Keywords

• Diagnostic pathology services
• Medical laboratory testing
• Pathology collection centres
• Specialty pathology diagnostics
• Clinical laboratory services

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medicare-rebatable pathology tests: Bulk billing for Medicare-eligible outpatient pathology tests, with maximum out-of-pocket cost of $210 per day
2. Private billing for specialized tests: Private fees applied for specialized diagnostic procedures, tests not referred under Medicare rules, or tests falling outside Medicare scope
3. Direct billing for overseas patients: Direct billing agreements with OSHC and OSV insurers (AHM OSHC, Allianz OSHC, Bupa, Medibank Private) for overseas students and visitors
4. Self-funded immunity screening: Self-funded testing program for healthcare employment immunity screening not covered by Medicare

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Douglass Hanly Moir Pathology operates a comprehensive diagnostic pathology practice delivering routine and specialty pathology testing through more than 500 collection centres, metropolitan and regional laboratories, and a 24/7 central laboratory across New South Wales and north-west Victoria. Services span clinical pathology, genetic testing, prenatal screening, dermatopathology, urological pathology, gynecological pathology, cardiology testing, drug and alcohol screening, and workplace pathology, with results delivered electronically to referring clinicians.

Product overview

Douglass Hanly Moir Pathology (DHM) is a comprehensive diagnostic pathology practice offering a broad portfolio of pathology testing services across New South Wales and north-west Victoria. The service operates through a network structure comprising a Central Laboratory, Metropolitan Laboratories, and Regional Laboratories, all part of the Sonic Healthcare group. The core diagnostic offerings span routine and specialty pathology tests including clinical pathology (blood tests, STI testing, allergy testing), genetic testing (NIPT, karyotyping, PGx, reproductive carrier screening), specialty services (GynaePath, Sonic Skin Dx, Sonic Uro Dx, Sonic Genetics, Cardiology, Gastrointestinal & Hepatic Pathology), and commercial pathology (Drug & Alcohol Testing, Workplace Testing, Health & Wellness Screening). Supporting digital platforms include Sonic Dx for electronic result delivery, eSupplies for supply ordering, Sonic Edu for clinician education, and My Health Record integration. Specialty offerings like MetaPanel (metagenomic GI pathogen testing) and patient comfort technology like Smileyscope (VR headsets) differentiate the service. The organization provides over 500 collection centres, 24-hour operation, and serves general practitioners, medical specialists, private hospitals, nursing homes, and community health services.

Differentiator

Problem solved

Functional benefit

Brands

• GynaePath: Gynaecological pathology services specializing in women's health diagnostics.
• Sonic Skin Dx
• Sonic Uro Dx
• Sonic Genetics
• MetaPanel
• eSupplies
• Sonic Dx
• Sonic Edu

Quantifiable outcome

• Medicare rebate eligible tests with maximum out-of-pocket of $210 per day
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Sonic HealthcarecoreStrategic or Co-development PartnerSonic Healthcare is the parent company of Douglass Hanly Moir Pathology, providing organizational infrastructure and shared resources across the Sonic Healthcare laboratory network.
• AHM OSHCminorChannel Partner/ Reseller/ DistributorDirect billing agreement for Overseas Student Health Cover holders to access DHM pathology services with reduced or no upfront payment.
• Allianz OSHCminorChannel Partner/ Reseller/ DistributorDirect billing agreement for Allianz Overseas Student Health Cover and Overseas Visitor Cover holders (policy must begin with 'P').
• BupaminorChannel Partner/ Reseller/ DistributorDirect billing agreement for Bupa OSHC holders to access DHM pathology services.
• Medibank PrivateminorChannel Partner/ Reseller/ DistributorDirect billing agreement for Medibank Private OSHC/OSV holders to access DHM pathology services.
• SmileyscopeminorStrategic or Co-development PartnerPartnership to provide virtual reality headsets at select collection centres to help patients remain calm and comfortable during blood draws and sample collection procedures.
• Sonic DxcoreTechnology or IntegrationElectronic results delivery platform for referring clinicians to download pathology results.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Laverty Pathology: A Healius-owned clinical pathology provider with strong NSW and ACT coverage; directly competes with DHM for GP referrals, collection-centre traffic, and specialist anatomical pathology work in overlapping Sydney metro regions.
• Australian Clinical Labs: ASX-listed clinical and anatomical pathology operator with national collection centre footprint; competes head-to-head with DHM on routine diagnostics, genetic testing, and corporate/workplace pathology in NSW and Victoria.
• QML Pathology: Healius-owned pathology network primarily serving Queensland; comparable to DHM in operating model and clinical service depth, providing a benchmark for collection-centre economics and GP referral stickiness.
• Dorevitch Pathology: A Healius pathology brand with deep Victorian coverage including Melbourne metro; overlapping with DHM's Mildura/north-west Victoria footprint and competing for hospital and GP referrals in shared geographies.
• Sullivan Nicolaides Pathology: Sonic Healthcare's flagship Queensland pathology brand and DHM's sister lab; shares group IT, procurement, and Sonic Dx, making it the most operationally analogous peer for benchmarking specialty subdiscipline coverage.
• Melbourne Pathology: Another Sonic Healthcare pathology brand focused on metropolitan Victoria; closely comparable in Medical Leadership model, pathologist-led specialty services, and integrated electronic results platform.
• Western Diagnostic Pathology: Healius pathology brand covering Western Australia; comparable collection-centre and laboratory operating model, useful for benchmarking regional pathology economics versus DHM's non-metro NSW footprint.
• Capital Pathology: Sonic Healthcare pathology brand serving ACT and southern NSW; shares Sonic Dx, Sonic Edu, and group-wide pathology protocols with DHM, making it the closest sister-lab peer in overlapping service area.
• Infinity Pathology: A specialty anatomic and molecular pathology provider aligned with Australian Clinical Labs; competes with DHM's Sonic Skin Dx, GynaePath, and Sonic Uro Dx for specialist dermatopathology and uropathology referrals.

Emerging players

• 4D Path: An emerging digital pathology platform applying AI to pathology workflows; overlaps with DHM at the pathology informatics layer and could either partner or compete as laboratory digital infrastructure evolves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCC_1_kZAHU7VRYq67WDOXWg
• Facebookfacebook.com/61560388596047
• LinkedInlinkedin.com/company/douglass-hanly-moir-pathology
• Instagraminstagram.com/dhmpathology

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Douglass Hanly Moir Pathology